Aposense

  • Home
  • About Us
    • Our mission and vision
    • Scientific president
    • Team
    • Board of directors
    • Scientific advisory board
    • Intellectual property
  • Our Technology
  • Our Platform
  • Investors
    • Presentations
    • Financial Reports
    • Stock Information
  • News Room
    • Press release
    • Publications
  • Other Projects
    • ATT-11T: Anti cancer pro-drug
    • ML-10
  • Contact Us


Postponement of a Shareholders Meeting – Update

Posted on September 23, 2014 by

The Company hereby announces that the Annual and Extraordinary General Meeting of the Company (originally scheduled for September 21, 2014), is postponed to October 7, 2014, at 10:00 AM (Israel time), Details regarding the General Meeting (including items on the agenda and voting instructions)

Posted in press release
Aposense

Contact Us

Telephone: + 972.73.239.7600
Fax: +972.3.921.57.14
E-mail: info@aposense.com

Careers

Latest news

  • EVENT: BIO INVESTOR Forum, October 17-18, San Francisco, California

    24 Sep 2017

  • EVENT: BIO-Europe, Berlin Germany 6-8 November

    14 Sep 2017

  • Convening of a Shareholders Meeting – August 2017

    13 Jul 2017

Aposense © 2018. Privacy Policy
  • Home
  • About Us
    ▼
    • Our mission and vision
    • Scientific president
    • Team
    • Board of directors
    • Scientific advisory board
    • Intellectual property
  • Our Technology
  • Our Platform
  • Investors
    ▼
    • Presentations
    • Financial Reports
    • Stock Information
  • News Room
    ▼
    • Press release
    • Publications
  • Other Projects
    ▼
    • ATT-11T: Anti cancer pro-drug
    • ML-10
  • Contact Us